Natus Medical traded at $32.96 this Wednesday July 20th, increasing $0.03 or 0.09 percent since the previous trading session. Looking back, over the last four weeks, Natus Medical gained 2.07 percent. Over the last 12 months, its price rose by 32.58 percent. Looking ahead, we forecast Natus Medical to be priced at 32.04 by the end of this quarter and at 29.42 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 291.12 -3.94 -1.34% -11.40%
AngioDynamics 23.88 -0.40 -1.65% -12.53%
Accuray 2.82 -0.15 -5.05% -20.56%
AtriCure 52.61 -0.01 -0.02% -28.53%
Boston Scientific 42.35 0.20 0.47% -6.20%
Cooper Companies 337.27 3.93 1.18% -23.10%
Artivion Inc 23.15 -0.10 -0.43% -9.68%
Cardiovascular Systems 16.72 -0.45 -2.62% -54.54%
Edwards Lifesciences 102.28 -2.46 -2.35% -12.78%
General Electric 81.07 1.26 1.58% -20.22%
Globus Medical 67.06 -0.48 -0.71% -14.10%
Integra LifeSciences 55.80 -1.02 -1.80% -22.42%
Inogen 31.80 0.95 3.08% -48.78%
Masimo 169.38 9.61 6.01% -38.57%
Medtronic 95.31 0.11 0.12% -27.11%
Mesa Laboratories 200.30 0.64 0.32% -25.97%
Orthofix International 22.28 -0.46 -2.02% -44.01%
Koninklijke Philips 20.59 0.49 2.44% -53.47%
Philips 19.70 -0.20 -1.00% -47.98%
PerkinElmer 156.30 -1.35 -0.86% -14.52%
Insulet 268.61 -2.03 -0.75% -11.30%
Surmodics 38.92 0.23 0.59% -28.31%
Thermo Fisher Scientific 602.11 -2.38 -0.39% 10.55%
Tandem Diabetes Care 54.75 -0.50 -0.91% -50.80%
Trinity Biotech 1.40 0.02 1.45% -36.94%

Indexes Price Day Year
USND 13103 -25.50 -0.19% -10.60%
US2000 2021 -0.82 -0.04% -7.19%

Natus Medical
Natus Medical Incorporated provides healthcare solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The Company provides product solutions for three end markets: Neuro, Newborn Care and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care and neurosurgery. Its Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management and various disposable newborn care supplies. Its Hearing portfolio includes products for hearing assessment and diagnostics and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Balance portfolio provides diagnosis and assessment of vestibular and balance disorders.